MT-TP and fatty liver disease: Those findings, coupled with the aforementioned observations, suggest that blocking chylomicron assembly in MCD-fed Mttp-IKO mice reduces hepatic steatosis and mitigates inflammatory and fibrogenic signaling through a combination of pathways, including altered cell signaling, damage-associated molecular pathway, and oxidative stress pathways.